Global Ophthalmic Drugs Market Size & Outlook, 2026-2033
Global ophthalmic drugs market, 2021-2033 (US$M)
Related Markets
Global ophthalmic drugs market highlights
- The global ophthalmic drugs market generated a revenue of USD 41,389.6 million in 2025 and is expected to reach USD 79,441.1 million by 2033.
- The market is expected to grow at a CAGR (2026 - 2033) of 8.5% by 2033.
- In terms of segment, anti-vegf agents accounted for a revenue of USD 15,584.8 million in 2025.
- Gene & Cell Therapy is the most lucrative drug class segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2025.
- Country-wise, India is expected to register the highest CAGR from 2026 to 2033.
Global data book summary
| Market revenue in 2025 | USD 41,389.6 million |
| Market revenue in 2033 | USD 79,441.1 million |
| Growth rate | 8.5% (CAGR from 2026 to 2033) |
| Largest segment | Anti-vegf agents |
| Fastest growing segment | Gene & Cell Therapy |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Anti-VEGF agents, Anti-glaucoma, Anti-inflammatory, Anti-Allergy, Gene & Cell Therapy |
Other key industry trends
- In terms of revenue, the North America accounted for 42.5% of the global ophthalmic drugs market in 2025.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, India is the fastest growing regional market and is projected to reach USD 2,495.2 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Ophthalmic Drugs Market Scope
Ophthalmic Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Nicox SA Share from reverse split | View profile | 29 | Rue Evariste Galois, Emerald Square, Batiment C, Sundesk Sophia Antipolis, Biot, France, 06410 | https://www.nicox.com |
| Coherus BioSciences Inc | View profile | 306 | 333 Twin Dolphin Drive, Suite 600, Redwood City, CA, United States, 94065 | https://www.coherus.com |
| Genentech | View profile | 10001+ | South San Francisco, California, United States, North America | http://gene.com |
| Bausch Health Companies Inc | View profile | 20270 | 2150 Saint Elzear Boulvard West, Laval, QC, Canada, H7L 4A8 | https://www.bauschhealth.com |
| Regeneron Pharmaceuticals Inc | View profile | 13450 | 777 Old Saw Mill River Road, Tarrytown, NY, United States, 10591-6707 | https://www.regeneron.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Alcon Inc | View profile | 25315 | Chemin de Blandonnet 8, Royce Bedward, Vernier, Geneva, Switzerland, 1214 | https://www.alcon.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Global ophthalmic drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ophthalmic drugs market will help companies and investors design strategic landscapes.
Anti-vegf agents was the largest segment with a revenue share of 37.65% in 2025. Horizon Databook has segmented the Global ophthalmic drugs market based on anti-vegf agents, anti-glaucoma, anti-inflammatory, anti-allergy, gene & cell therapy covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Ophthalmic Drugs Drug Class Outlook (Revenue, USD Million, 2021-2033)
- Anti-VEGF agents
- Others
- Anti-glaucoma
- Anti-inflammatory
- Non-steroidal drugs
- Steroids
- Anti-Allergy
- Gene & Cell Therapy
- Global Ophthalmic Drugs Disease Outlook (Revenue, USD Million, 2021-2033)
- Dry Eye
- Eye solutions & suspensions
- Capsules & Tablets
- Eye drops
- Gels
- Ointments
- Glaucoma
- Gels
- Eye drops
- Eye solutions & suspensions
- Capsules & Tablets
- Ointments
- Retinal Disorders
- Eye solutions & suspensions
- Eye drops
- Gels
- Capsules & Tablets
- Ointments
- Allergies
- Gels
- Eye solutions & suspensions
- Eye drops
- Capsules & Tablets
- Ointments
- Infection
- Capsules & Tablets
- Eye solutions & suspensions
- Eye drops
- Gels
- Ointments
- Uveitis
- Eye solutions & suspensions
- Capsules & Tablets
- Eye drops
- Ointments
- Gels
- Others
- Eye drops
- Ointments
- Gels
- Eye solutions & suspensions
- Capsules & Tablets
- Dry Eye
- Global Ophthalmic Drugs Route of Administration Outlook (Revenue, USD Million, 2021-2033)
- Topical
- Local Ocular
- Subconjunctival
- Intravitreal
- Retrobulbar
- Intracameral
- Systemic
- Global Ophthalmic Drugs Dosage Type Outlook (Revenue, USD Million, 2021-2033)
- Gels
- Ointments
- Eye solutions & suspensions
- Capsules & Tablets
- Eye drops
- Global Ophthalmic Drugs Product Type Outlook (Revenue, USD Million, 2021-2033)
- Prescription
- OTC drugs
- Global Ophthalmic Drugs Drug Type Outlook (Revenue, USD Million, 2021-2033)
- Branded Drugs
- Generic Drugs
Reasons to subscribe to Global ophthalmic drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global ophthalmic drugs market databook
-
Our clientele includes a mix of ophthalmic drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global ophthalmic drugs market , including forecasts for subscribers. This global databook contains high-level insights into Global ophthalmic drugs market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global ophthalmic drugs market size, by regions, 2021-2033 (US$M)
Top 10 countries: Ophthalmic drugs market size, 2025 (US$M)
Global ophthalmic drugs market share, by drug class, 2025 & 2033 (%, US$M)
Ophthalmic drugs market: Opportunity assessment by country
Global ophthalmic drugs market, by region, 2025 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
